In Vitro Screening for ToxCast Chemicals Binding to Thyroxine-Binding Globulin by Stephanie A. Eytcheson (4284421)

Subjects:

The Characteristic of S100A7 Induction by the Hippo-YAP Pathway in Cervical and Glossopharyngeal Squamous Cell Carcinoma by Fei Kong (161761)

“…In well differentiated HCC94 cervical cells and FaDu pharyngeal cells, S100A7 is easily induced by both suspension and dense culture, which is accompanied by an increase in YAP phosphorylation and a decrease in nuclear YAP. …”

S100A9 treatment decreases the secretion of pro-inflammatory cytokines (A) 5 days after LPS injection, sera were collected and tested for IL-6 by ELISA. by Annabelle Cesaro (112070)

Table_1_Urban-driven decrease in arthropod richness and diversity associated with group-specific changes in arthropod abundance.DOCX by Marion Chatelain (3317994)

“…Urbanisation level was estimated by five different proxies extracted from land use/land cover data (e.g., impervious surface cover), all of them calculated in a 100, 500, and 1,000 m radius around the sampling points, and three indexes based on distance to settlements. …”

Effect of ursodeoxycholic acid (150 mg/kg, p.o.) and fenofibrate (100 mg/kg, p.o.) on aortic malondialdehyde (MDA) content (a) and aortic reduced glutathione (GSH) content (b) in f... by Amr A. A. Mahmoud (627688)

LPS decreases only T cell proliferative response to OKT3. by Fanny Poujol (834338)

HDAC inhibition by quisinostat synergizes with proteasome inhibition to decrease synovial sarcoma cell viability. by Aimée N. Laporte (3617987)

Subjects:

Phospho-ERK level is decreased in 3D spheroids. by Keven Huang (675616)

“…(<b>C</b>) At 100,000 cells per spheroid, HeyA8 cells treated with SDF-1α and PMA showed activation of phospho-ERK levels. (**, P <0.005 vs Adh, 1-way ANOVA). …”

MCF-7 cells were treated with 0, 10, or 20 μM of Peptide 1 or Peptide 2 for 48h. by Deepu Dowarha (5673440)

Subjects:

S100A1 complete sequence indicating highlighted region selected for peptide construction, attaching it to HIV-TAT peptide forming Peptide 1 and its scramble arrangement in Peptide... by Deepu Dowarha (5673440)

Subjects:

Fig 9 - by Deepu Dowarha (5673440)

Subjects:

The p53-MDM2 interaction was monitored via fluorescence spectroscopy. by Deepu Dowarha (5673440)

Subjects:

Analysis of WST-1 assay. by Deepu Dowarha (5673440)

Subjects:

The ¹H−¹⁵N HSQC spectra overlay of free ¹⁵N p53 (1–73) (red) and in complex with unlabelled S100A1 (yellow). by Deepu Dowarha (5673440)

Subjects:

Fig 16 - by Deepu Dowarha (5673440)

Subjects:

Competitive binding experiment. by Deepu Dowarha (5673440)

Subjects:

The MCF-7 and/or MDA-MB-468 cells were treated with or without 10 μM Peptide 1 for 48h. by Deepu Dowarha (5673440)

Subjects:

The p53-Peptide 1 interaction was monitored via fluorescence spectroscopy. by Deepu Dowarha (5673440)

Subjects:

Supplementary Material for: Decreased Systemic Levels of Endocan-1 and CXCL16 in Psoriasis Are Restored following Narrowband UVB Treatment by Sigurdardottir G. (5710955)

Fig 5 - by Wenqi Zhang (2953815)